PlumX Metrics
Embed PlumX Metrics

A Stem-like Patient-Derived Ovarian Cancer Model of Platinum Resistance Reveals Dissociation of Stemness and Resistance

International Journal of Molecular Sciences, ISSN: 1422-0067, Vol: 25, Issue: 7
2024
  • 1
    Citations
  • 0
    Usage
  • 1
    Captures
  • 2
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

  • Citations
    1
  • Captures
    1
  • Mentions
    2
    • Blog Mentions
      1
      • Blog
        1
    • News Mentions
      1
      • News
        1

Most Recent News

Loma Linda University Researcher Has Provided New Study Findings on Ovarian Cancer (A Stem-like Patient-Derived Ovarian Cancer Model of Platinum Resistance Reveals Dissociation of Stemness and Resistance)

2024 APR 16 (NewsRx) -- By a News Reporter-Staff News Editor at NewsRx Women's Health Daily -- Current study results on ovarian cancer have been

Article Description

To understand chemoresistance in the context of cancer stem cells (CSC), a cisplatin resistance model was developed using a high-grade serous ovarian cancer patient-derived, cisplatin-sensitive sample, PDX4. As a molecular subtype-specific stem-like cell line, PDX4 was selected for its representative features, including its histopathological and BRCA2 mutation status, and exposed to cisplatin in vitro. In the cisplatin-resistant cells, transcriptomics were carried out, and cell morphology, protein expression, and functional status were characterized. Additionally, potential signaling pathways involved in cisplatin resistance were explored. Our findings reveal the presence of distinct molecular signatures and phenotypic changes in cisplatin-resistant PDX4 compared to their sensitive counterparts. Surprisingly, we observed that chemoresistance was not inherently linked with increased stemness. In fact, although resistant cells expressed a combination of EMT and stemness markers, functional assays revealed that they were less proliferative, migratory, and clonogenic–features indicative of an underlying complex mechanism for cell survival. Furthermore, DNA damage tolerance and cellular stress management pathways were enriched. This novel, syngeneic model provides a valuable platform for investigating the underlying mechanisms of cisplatin resistance in a clinically relevant context, contributing to the development of targeted therapies tailored to combat resistance in stem-like ovarian cancer.

Bibliographic Details

Suzuki, Tise; Conant, Ashlyn; Jung, Yeonkyu; Bax, Ryan; Antonissen, Ashley; Chen, Wanqiu; Yu, Gary; Ioffe, Yevgeniya J; Wang, Charles; Unternaehrer, Juli J

MDPI AG

Chemical Engineering; Biochemistry, Genetics and Molecular Biology; Chemistry; Computer Science

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know